In last trading session, Conduit Pharmaceuticals Inc (NASDAQ:CDT) saw 252.23 million shares changing hands with its beta currently measuring 2.26. Company’s recent per share price level of $0.08 trading at -$0.01 or -12.77% at ring of the bell on the day assigns it a market valuation of $9.83M. That closing price of CDT’s stock is at a discount of -6350.0% from its 52-week high price of $5.16 and is indicating a premium of 37.5% from its 52-week low price of $0.05. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 64.97 million shares which gives us an average trading volume of 31.34 million if we extend that period to 3-months.

Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information

Upright in the red during last session for losing -12.77%, in the last five days CDT remained trading in the green while hitting it’s week-highest on Wednesday, 01/08/25 when the stock touched $0.08 price level, adding 39.3% to its value on the day. Conduit Pharmaceuticals Inc’s shares saw a change of 19.53% in year-to-date performance and have moved 19.53% in past 5-day. Conduit Pharmaceuticals Inc (NASDAQ:CDT) showed a performance of -11.92% in past 30-days. Number of shares sold short was 3.57 million shares which calculate 0.14 days to cover the short interests.

Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders

Insiders are in possession of 49.12% of company’s total shares while institution are holding 4.06 percent of that, with stock having share float percentage of 7.97%. Investors also watch the number of corporate investors in a company very closely, which is 4.06% institutions for Conduit Pharmaceuticals Inc that are currently holding shares of the company.